A testing dose was unnecessary, Novartis believed, given that valsartan 320mg (160mg twice a day) had been tested in heart failure and with a 1:1 ratio with sacubitril. "I had nothing to learn ...

The drug was developed over 20 years ago by Novartis and since then has been very frequently prescribed to treat patients with high blood pressure. Valsartan has been also used to prevent heart ...

Sacubitril and Valsartan tablets are the generic equivalent of Novartis' Entresto, used to reduce cardiovascular risks in ...

The company has received final approval from the US Food & Drug Administration (USFDA) for Sacubitril and Valsartan Tablets ... therapeutically equivalent to Novartis's Entresto tablets.